Henrik Stenqvist
Vermögen: 6 Mio $ am 30.06.2026
Vermögen: 6 Mio $ am 30.06.2026
Gegenwärtig ist Henrik Stenqvist Chief Financial Officer bei Swedish Orphan Biovitrum AB und Co-Geschäftsführer bei Swedish Orphan Biovitrum GmbH (einer Tochtergesellschaft von Swedish Orphan Biovitrum AB). Herr Stenqvist ist außerdem im Aufsichtsrat von Midsona AB, Dova Pharmaceuticals, Inc. und Swedish Orphan Biovitrum, Inc. Henrik Stenqvist war zuvor Chief Financial Officer & Executive Vice President bei Recipharm AB, Chief Financial Officer bei Calliditas Therapeutics AB, Finance Director bei Astra Export & Trading AB, Chief Financial Officer bei MEDA Manufacturing GmbH und Chief Financial Officer, EVP-Finance & Procurement bei Meda AB. Henrik Stenqvist erwarb einen MBA und einen Bachelor-Abschluss an der Universität Linkping.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.07.2026 | 111’246 ( 0.03% ) | 5 Mio $ | 30.06.2026 | |
| 31.12.2025 | 2’971 ( 0% ) | 244 396 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Finanzdirektor/CFO | 20.07.2018 |
| DOVA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 12.11.2019 |
| CTI BIOPHARMA CORP. | Treasurer | - |
| ORION OYJ | Direktor/Vorstandsmitglied | 20.03.2024 |
Swedish Orphan Biovitrum Ltd.
Swedish Orphan Biovitrum Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs for rare diseases | Direktor/Vorstandsmitglied | 20.07.2018 |
Swedish Orphan Biovitrum GmbH
Swedish Orphan Biovitrum GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching,developing and innovating therapies that improve the lives of people with rare diseases | Vorstandsvorsitzender | - |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| MIDSONA AB | Direktor/Vorstandsmitglied | 07.05.2024 |
| RECIPHARM AB (PUBL) | Finanzdirektor/CFO | 01.01.2018 |
| ░░░░ ░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 16 |
|---|---|
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Orion Oyj
Orion Oyj Pharmaceuticals: MajorHealth Technology Manufactures and markets human and veterinary pharmaceuticals | Health Technology |
Meda AB
Meda AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Recipharm AB
Recipharm AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract development and manufacturing organization | Health Technology |
MEDA Manufacturing GmbH
MEDA Manufacturing GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
MedCap AB
MedCap AB Medical SpecialtiesHealth Technology Manufactures and sells radiological & ECG equipment, probiotics and nutritional supplements | Health Technology |
Calliditas Therapeutics AB
Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
University of Linköping
University of Linköping Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Midsona AB
Midsona AB Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets nutritional supplements | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Astra Export & Trading AB | |
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Swedish Orphan Biovitrum GmbH
Swedish Orphan Biovitrum GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching,developing and innovating therapies that improve the lives of people with rare diseases | Commercial Services |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Swedish Orphan Biovitrum Ltd.
Swedish Orphan Biovitrum Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs for rare diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen